(Q40550460)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Yamanouchi Y

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Iwata N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Suzuki T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kitajima T

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ikeda M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

The Pharmacogenomics Journal

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

356-361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14610521%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500211

20 December 2019

exact match

0 references

cites work

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

PCR detection of the TaqA RFLP at the DRD2 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

A highly significant association between a COMT haplotype and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

A New Statistical Method for Haplotype Reconstruction from Population Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

Association between clozapine response and allelic variation in 5-HT2A receptor gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

Network interactions in schizophrenia - therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

SCID-PANSS: two-tier diagnostic system for psychotic disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500211

7 January 2021